1
1135 A 51-year-old man walks into an emergency department with mild left anterior chest pain. He denies any significant personal or family history of heart disease and he has no other cardiac risk factors. Physical examination reveals minimal bibasilar rates and is otherwise normal. An electrocardiogram (ECG) reveals slight T-wave flattening. The doctor then enters all the pertinent information accrued from the patient into the on-line emergency department patient medical record and management system. That system includes a neural network trained to identify acute myocardial infarction. The network analyses this information and relays the fact, via an on-screen window, that this patient has sustained a myocardial infarction. The physician combines this information with his own impression and admits the patient to the coronary-care unit. 4 h later cardiac enzyme studies confirm acute myocardial infarction. This scenario is based on a real network, representing one of the first applications of artificial neural networks to clinical medicine. Preliminary studies have revealed that this network is more accurate than physicians in identifying acute myocardial infarction in patients presenting to the emergency department with anterior chest pain. Many biological and pathophysiological processes manifest "chaotic" behaviour. Chaotic processes are not best analysed by classical linear methods. The first article in this series, by Cross and colleagues,’ explained how non-linear processing, as afforded by an artificial neural network, might improve upon the predictive power of the other approaches. The hope has been that the network’s ability to identify multidimensional relationships in clinical data not apparent to other forms of analyses would allow the network to improve diagnostic accuracy. Non-linear statistical methods have been tried before but they were complex and computationally intensive and never became widely accepted. The advent of the artificial neural network and the much greater speed of today’s computers have changed this. Clinical diagnosis became one of the first areas to which the artificial neural network was applied. Acute myocardial infarction was one of the earliest applications but the range is wide, from appendicitis to the examination of biopsy specimens (panel 1). Starting with myocardial infarction this review will cover some of those clinical applications. The use of neural networks in the laboratory will be covered by Dybowski and Gant in the last article in this Lancet series.2 Myocardial infarction Myocardial infarction is especially challenging because it is a disease of low incidence yet a very high price has to be paid for its misdiagnosis. As a result, physicians have tended to err on the side of safety: they push their Lancet 1995; 346: 1135-38 Department of Emergency Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA (W G Baxt MD) diagnostic sensitivity as high as possible, leading to a reduction in specificity and the unnecessary admission to hospital of significant numbers of patients who have not had a myocardial infarction. A large study published i 1988 put physicians’ sensitivity at 88% and specificity a 71%." The first application of the artificial neural network to chest pain appeared in 1989.12 This work trained a multilayer network on 174 patients presenting with anterior chest pain and it put patients into one of three diagnostic groups-high risk cardiac, low risk cardiac, and non-cardiac. However, these areas were not defined by any standard criteria. Another application was based on a retrospective study of a set of 356 patients admitted to a cardiac intensive care unit. 120 had had a myocardial infarction. The network was trained, using back- propagation, on half of the patients with and without myocardial infarction, and it was tested on the remaining patients, to whom the network had not been exposed. Clinical pharmacology Predicting: tumour sensitivity to drugs, patient’s 58-60 response to warfarin, and central-nervous- system activity of alfentanil

Science

  • Upload
    fiona

  • View
    3

  • Download
    2

Embed Size (px)

Citation preview

  • Application of artificial neural networks to clinical medicine

    1135

    A 51-year-old man walks into an emergency departmentwith mild left anterior chest pain. He denies anysignificant personal or family history of heart disease andhe has no other cardiac risk factors. Physical examinationreveals minimal bibasilar rates and is otherwise normal.An electrocardiogram (ECG) reveals slight T-waveflattening. The doctor then enters all the pertinentinformation accrued from the patient into the on-lineemergency department patient medical record andmanagement system. That system includes a neuralnetwork trained to identify acute myocardial infarction.The network analyses this information and relays the fact,via an on-screen window, that this patient has sustained amyocardial infarction. The physician combines thisinformation with his own impression and admits thepatient to the coronary-care unit. 4 h later cardiac enzymestudies confirm acute myocardial infarction.This scenario is based on a real network, representing

    one of the first applications of artificial neural networks toclinical medicine. Preliminary studies have revealed thatthis network is more accurate than physicians inidentifying acute myocardial infarction in patientspresenting to the emergency department with anteriorchest pain.Many biological and pathophysiological processes

    manifest "chaotic" behaviour. Chaotic processes are notbest analysed by classical linear methods. The first articlein this series, by Cross and colleagues, explained hownon-linear processing, as afforded by an artificial neuralnetwork, might improve upon the predictive power of theother approaches. The hope has been that the networksability to identify multidimensional relationships inclinical data not apparent to other forms of analyseswould allow the network to improve diagnostic accuracy.Non-linear statistical methods have been tried before butthey were complex and computationally intensive andnever became widely accepted. The advent of the artificialneural network and the much greater speed of todayscomputers have changed this.

    Clinical diagnosis became one of the first areas towhich the artificial neural network was applied. Acutemyocardial infarction was one of the earliest applicationsbut the range is wide, from appendicitis to theexamination of biopsy specimens (panel 1). Starting withmyocardial infarction this review will cover some of thoseclinical applications. The use of neural networks in thelaboratory will be covered by Dybowski and Gant in thelast article in this Lancet series.2

    Myocardial infarctionMyocardial infarction is especially challenging because itis a disease of low incidence yet a very high price has to bepaid for its misdiagnosis. As a result, physicians havetended to err on the side of safety: they push theirLancet 1995; 346: 1135-38

    Department of Emergency Medicine, University of PennsylvaniaMedical Center, Philadelphia, PA 19104-4283, USA (W G Baxt MD)

    diagnostic sensitivity as high as possible, leading to areduction in specificity and the unnecessary admission tohospital of significant numbers of patients who have nothad a myocardial infarction. A large study published in1988 put physicians sensitivity at 88% and specificity at71%."The first application of the artificial neural network to

    chest pain appeared in 1989.12 This work trained amultilayer network on 174 patients presenting withanterior chest pain and it put patients into one of threediagnostic groups-high risk cardiac, low risk cardiac,and non-cardiac. However, these areas were not definedby any standard criteria. Another application was basedon a retrospective study of a set of 356 patients admittedto a cardiac intensive care unit. 120 had had a myocardialinfarction. The network was trained, using back-propagation, on half of the patients with and withoutmyocardial infarction, and it was tested on the remainingpatients, to whom the network had not been exposed.

    Clinical pharmacologyPredicting: tumour sensitivity to drugs, patients 58-60response to warfarin, and central-nervous-system activity of alfentanil